[Expression of p53 in neonatal mice following hypoxia-ischemia and effects of its inhibitor on neonatal brain injury]. 2006

Fa-Lin Xu, and Chang-Lian Zhu, and Xiao-Yang Wang, and Lin Qiu, and Ling Ji, and Xiu-Yong Cheng, and Bin Luan
Department of Pediatrics, Third Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China. xufalin72@126.com

OBJECTIVE p53-induced apoptosis is crucial in the development of hypoxic-ischemia (HI) brain damage and neurodegenerative disorders. Some experimental research has shown that a synthetic inhibitor of p53 can protect neurons against apoptosis. This study aimed to explore the expression of p53 in neonatal mice following HI brain damage and the effect of p53 inhibitor (pifithrin-alpha, PFT-alpha) on brain damage. METHODS HI was induced in 9-day-old mice pups by ligation of left carotid artery and 10% oxygen exposure for 55 minutes. The pups were sacrificed and the brains were taken out at 3, 8, 24, and 72 hrs post-HI. The brains were sectioned and stained with antibody against p53 and microtubule-associated protein 2 (MAP-2). PFT-alpha was injected intraperitoneally: in experiment 1, immediately after HI with different dosages (1, 2 and 8 mg/kg); in experiment 2, 2 mg/kg at different HI times (1 hr before HI, and immediately and 1 hr after HI). Control animals without HI received injections of 0.5% dimethyl sulfoxide. Brain damage was evaluated by gross morphology scoring at 72 hrs after HI. RESULTS The number of p53 positive cells in the cortex, hippocampus and striatum of the ipsilateral hemisphere increased significantly and peaked at 3-8 hrs post-HI when compared with those of contralateral hemisphere as well as normal controls. The positive cells distributed mainly in the MAP-2 negative area. Both different dosages and different injection time PFT-alpha treatment did not reduce the extent of brain damage. CONCLUSIONS The immunoactivity of p53 increased significantly as early as 3 hrs post-HI. The distribution area of p53 expression was consistent with that of brain damage. The p53 inhibitor PFT-alpha has no protective effects against HI brain damage in neonatal mice.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D008297 Male Males
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005260 Female Females
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000831 Animals, Newborn Refers to animals in the period of time just after birth. Animals, Neonatal,Animal, Neonatal,Animal, Newborn,Neonatal Animal,Neonatal Animals,Newborn Animal,Newborn Animals
D013844 Thiazoles Heterocyclic compounds where the ring system is composed of three CARBON atoms, a SULFUR and NITROGEN atoms. Thiazole
D014050 Toluene A widely used industrial solvent.

Related Publications

Fa-Lin Xu, and Chang-Lian Zhu, and Xiao-Yang Wang, and Lin Qiu, and Ling Ji, and Xiu-Yong Cheng, and Bin Luan
September 2021, Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology,
Fa-Lin Xu, and Chang-Lian Zhu, and Xiao-Yang Wang, and Lin Qiu, and Ling Ji, and Xiu-Yong Cheng, and Bin Luan
January 2022, Developmental neuroscience,
Fa-Lin Xu, and Chang-Lian Zhu, and Xiao-Yang Wang, and Lin Qiu, and Ling Ji, and Xiu-Yong Cheng, and Bin Luan
June 2018, Metabolic brain disease,
Fa-Lin Xu, and Chang-Lian Zhu, and Xiao-Yang Wang, and Lin Qiu, and Ling Ji, and Xiu-Yong Cheng, and Bin Luan
June 2019, Molecular medicine reports,
Fa-Lin Xu, and Chang-Lian Zhu, and Xiao-Yang Wang, and Lin Qiu, and Ling Ji, and Xiu-Yong Cheng, and Bin Luan
September 2004, Stroke,
Fa-Lin Xu, and Chang-Lian Zhu, and Xiao-Yang Wang, and Lin Qiu, and Ling Ji, and Xiu-Yong Cheng, and Bin Luan
February 2017, Physiology & behavior,
Fa-Lin Xu, and Chang-Lian Zhu, and Xiao-Yang Wang, and Lin Qiu, and Ling Ji, and Xiu-Yong Cheng, and Bin Luan
November 1998, Brain research,
Fa-Lin Xu, and Chang-Lian Zhu, and Xiao-Yang Wang, and Lin Qiu, and Ling Ji, and Xiu-Yong Cheng, and Bin Luan
June 2019, Experimental and therapeutic medicine,
Fa-Lin Xu, and Chang-Lian Zhu, and Xiao-Yang Wang, and Lin Qiu, and Ling Ji, and Xiu-Yong Cheng, and Bin Luan
June 2010, Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics,
Fa-Lin Xu, and Chang-Lian Zhu, and Xiao-Yang Wang, and Lin Qiu, and Ling Ji, and Xiu-Yong Cheng, and Bin Luan
January 2007, Neurobiology of learning and memory,
Copied contents to your clipboard!